行情

CANF

CANF

灿菲特生物制药
AMEX
0.7678
-0.0222
-2.81%
交易中 13:32 09/29 EDT
开盘
0.7730
昨收
0.7900
最高
0.7730
最低
0.7650
成交量
4.01万
成交额
1.17万
52周最高
2.600
52周最低
0.7401
市值
2,087.77万
市盈率(TTM)
-1.1633
分时
5日
1月
3月
1年
5年
暂无数据
CANF 简况
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

微牛提供Can Fite Biopharma Ltd(AMEX-CANF)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CANF股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CANF股票基本功能。